Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Observation of Bupivacaine Liposome for Lower Extremity Nerve Block
Sponsor: Hainan Medical College
Summary
This prospective, sequential dose-finding clinical observational study aims to estimate the median effective concentration (EC50) and the 95% effective concentration (EC95) of liposomal bupivacaine for ultrasound-guided femoral nerve block. Sensory and motor block endpoints are evaluated separately at 30 minutes after block placement using a modified up-and-down (sequential allocation) design, with trial termination after eight reversal points.
Official title: Clinical Observation of Bupivacaine Liposome for Lower Extremity Femoral Nerve Block
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-02
Completion Date
2026-03
Last Updated
2026-01-26
Healthy Volunteers
No
Conditions
Interventions
Liposomal bupivacaine, 266mg
Liposomal bupivacaine administered for ultrasound-guided femoral nerve block at varying concentrations using a modified up-and-down sequential dose-finding design.
Locations (1)
Department of Anesthesiology,the Second Affiliated Hospital of Hainan Medical University
Haikou, Hainan, China